Thermo Fisher Scientific (TMO) delivered mixed results in FY2026 on revenue of $37.7B versus the $38.0B estimate (+24.8% YoY) and EPS of $1.73. Below is the full Thermo Fisher Scientific earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$37.7B (vs $38.0B est · -0.8% surprise · +24.8% YoY)
EPS
$1.73 (vs $1.77 est · -2.3% surprise · +37.5% YoY)
Share price
$519.58 (-2.7%)
Market cap
$1.72T
What you'll find
Next Thermo Fisher Scientific (TMO) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Thermo Fisher Scientific reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Thermo Fisher Scientific (TMO)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Thermo Fisher Scientific's next earnings date?
Magnisto tracks Thermo Fisher Scientific's (TMO) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did Thermo Fisher Scientific (TMO) beat or miss earnings?
In FY2026, Thermo Fisher Scientific (TMO) posted mixed results — revenue of $37.7B versus the $38.0B estimate (-0.8% surprise) and EPS of $1.73 versus $1.77 expected (-2.3% surprise). Magnisto decodes every Thermo Fisher Scientific (TMO) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Thermo Fisher Scientific (TMO) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Thermo Fisher Scientific (TMO), anchored to the current $519.58 share price, so you can weigh the bull, base and bear cases for Thermo Fisher Scientific side by side.
Is Thermo Fisher Scientific (TMO) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Thermo Fisher Scientific fits your own thesis and risk profile. This is research, not investment advice.